Sandoz Group AG
Health Care
Current price
Target price 00%
Ranks rating
76
Position in sub-industry
797 / 1328
Position in country
306 / 449
Revenue CAGR 3Y, %
1
8.5
P/E
164.8
22.7
P/BV
1.4
1.5
P/S
1.2
2.3
EV/S
1.6
2.4
EV/EBITDA
8.9
7.4
Average Analyst recommendation
Buy
Buy
Average upside forecasts, %
31.8
51.3
Forward P/E
10.5
15.6
Dividend Yield, %
1.7
1.7
Forward Dividend Yield, %
2.3
0.2
Expected dividend per share
0.6
0
Dividend Ex Date
2024-05-03
Competitors
Ranks
-
Novo Nordisk A/S
00%
-
Vifor Pharma AG
00%
-
AstraZeneca PLC
00%
-
Eli Lilly and Co
00%
-
Roche Holding AG
00%
-
Dottikon Es Holding AG
00%
-
Novartis AG
00%
-
Sandoz Group AG
00%
-
Johnson & Johnson
00%
-
Merck & Co Inc
00%
Ready-made portfolio of the best Russian stocks
- Created by artificial intelligence
- Verified by analysts
- Available even to beginners
Company information
Country
Switzerland
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Pharmaceuticals
Sub-sector
Health Care
Capitalization (millions of $)
12689.5
Ticker
SDZNY.PK
ISIN
US7999261008
IPO date
2023-10-04
Availability on Russian exchanges
No
Reporting for
Date fact. publication of reports
Company Description
A step towards better analytics
- find the best promotions through the Screener
- keep an eye on stock valuation
- download detailed reports
and much more after free registration
RegistrationMore convenient from your phone? Download: